Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lord Jones is a luxury wellness brand that specializes in the development and distribution of premium hemp-derived CBD and cannabis products. The company's portfolio includes a variety of CBD-infused topicals, tinctures, and handcrafted edibles designed for pain management, stress reduction, and skincare. Established in 2016, Lord Jones became a pioneer in the "prestige CBD" category, securing high-end retail partnerships with companies like Sephora. In 2019, the brand was acquired by Cronos Group for approximately $300 million, and it has since expanded its footprint into the Canadian adult-use cannabis market. The brand is recognized for its commitment to quality, aesthetic design, and precise cannabinoid delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lord Jones.